Table 2.
Location | Year | n | Resistant isolates without known mechanisms | Reference | Accession |
---|---|---|---|---|---|
United States | 2009–2010 | 236 | - | Grad et al. 201450 | PRJEB2999 |
Canada | 1982–2008 | 25 | - | Vidovic et al. 2014159 | - |
Canada | 1989–2013 | 169 | 27 CRO-RS without mosaic penA | Demczuk et al. 2015160 | PRJNA266539 |
Global | 1982–2013 | 61 | 1 CFX-RS 1 AZI-RS 1 TET-R |
Ezewudo et al. 201521 | SRA099559 |
England | 2014–2015 | 15 | - | Chisholm et al. 201678 | - |
France | 2010–2014 | 4 | 1 AZI-RS | de Curraize et al. 2016161 | PRJEB13093 |
Canada | 1989–2014 | 236 | - | Demczuk et al. 2016162 | SRP065041 |
UK | 2004–2015 | 1842 | - | De Silva et al. 201624 | PRJNA315363 |
UK | 1995–2000 | 237 | - | Didelot et al. 2016107 | PRJEB2124 |
United States | 2000–2013 | 1102 | 106 AZI-RS 5 CIP-R |
Grad et al. 201622 | PRJEB7904 |
Global | 289 | - | Harrison et al. 201637 | Previously published | |
Europe | 2009–2014 | 75 | - | Jacobsson et al. 201679 | PRJNA322768 |
Global | 14 | - | Unemo et al. 2016139 | PRJEB14020 | |
UK | 2014–2015 | 100 | - | Peters et al. 2017111 | Previously published |
US, Brazil | 804 + 118 | - | Vidyaprakash et al. 2017163 | Previously published | |
Ireland | 2008–2014 | 14 | - | Mac Aogáin et al. 2017164 | PRJNA275092 |
New Zealand | 2014–2015 | 398 | 2 CIP-R 6 Spec-RS 1 CFX-RS |
Lee et al. 201723 | PRJNA394216 |
US (Hawaii) | 2011–2016 | 61 | - | Papp et al. 201790 | - |
Australia | 2005–2014 | 94 | Kwong et al. 2017165 | PRJEB17738 | |
Brazil | 2006–2015 | 116 | 3 PEN-R | Costa-Lourenço et al. 2018166 | - |
Australia | 2012–2014 | 94 | - | Buckley et al. 2018112 | PRJNA392203 |
UK | 2014–2017 | 180 | - | Fifer et al. 2018167 | PRJEB23008 |
Australia | 2011–2013 | 59 | - | Al Suwayyid et al. 2018168 | - |
Kenya | 2010–2015 | 103 | - | Cehovin et al. 2018169 | PRJEB10104 |
Japan, Australia | 2015, 2017 | 4 | - | Lahra et al. 2018170 | PRJNA416507 |
Studies were included when > 1 isolate was sequenced. -R = resistant, -RS = reduced susceptibility.